saccharomyces cerevisiae
Cell therapyexperimental
Baker's yeast is the common name for the strains of yeast commonly used in baking bread and other bakery products, serving as a leavening agent which causes the bread to rise by converting the fermentable sugars present in the dough into carbon dioxide and ethanol. Baker's yeast is of the species Saccharomyces cerevisiae, and is the same species as the kind commonly used in alcoholic fermentation, which is called brewer's yeast or the deactivated form nutritional yeast. Baker's yeast is also a single-cell microorganism found on and around the human body. — Wikipedia
Clinical trial activity
12 trials · 16 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
2
Phase 3
1
Phase 4
0
Earliest trial started Aug 1, 2004 (NCT00145093)
Timeline
Indications
Mechanism of action
- microbiotaTissue restoration
microbiota tissue restoration
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaBaker's yeast ↗
- NCATS978D8U419H ↗
- WikipediaSaccharomyces cerevisiae ↗
Also known as
- baker's yeast
- saccharomyces cerevisiae cncm i-3856
- yeast cells
- zinc-enriched yeast
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05136378 | N/A | Nov 1, 2021 | Fudan University, Second Military Medical University |
| NCT05149599 | Phase 1/Phase 2 (Phase 2) | Mar 1, 2021 | Hilton Pharma, Ziauddin University |
| NCT03484026 | N/A | May 17, 2018 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Pennsylvania State University, Sidero Bioscience, LLC |
| NCT03574844 | N/A | Mar 1, 2018 | Biofortis, Lesaffre International |
| NCT03150212 | N/A | Mar 20, 2017 | Biofortis, Lesaffre International |
| NCT02990260 | N/A | Dec 1, 2016 | Lesaffre International |
| NCT02814695 | Early Phase 1 (Phase 1) | Aug 1, 2015 | Benha University, Zagazig University |
| NCT02345096 | N/A | Jan 1, 2015 | Eurofins, Lesaffre International |
| NCT02292303 | N/A | Oct 1, 2014 | Lesaffre International |
| NCT01613456 | N/A | Dec 1, 2011 | Biofortis, Lesaffre International, University of Nottingham |
| NCT00977587 | N/A | Jan 1, 2011 | Lesaffre International, University of Nottingham |
| NCT00145093 | Phase 3 | Aug 1, 2004 | Isala Clinics, Zwolle, The Netherlands, Medical Research Foundation, The Netherlands, Pharma Nord |
Showing 12 of 12 trials
Page 1 / 1
Organizations
Research & Development (16)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Lesaffre International | For profit | 7 | 6 | 1 | 2011 |
| Biofortis | For profit | 3 | 0 | 1 | 2011 |
| University of Nottingham | Academic/Hospital | 2 | 1 | 1 | 2011 |
| Benha University | Academic/Hospital | 1 | 1 | 1 | 2015 |
| Eurofins | For profit | 1 | 0 | 1 | 2015 |
| Fudan University | Academic/Hospital | 1 | 1 | 1 | 2021 |
| Hilton Pharma | For profit | 1 | 0 | 1 | 2021 |
| Isala Clinics, Zwolle, The Netherlands | Academic/Hospital | 1 | 0 | 1 | 2004 |
| Medical Research Foundation, The Netherlands | Academic/Hospital | 1 | 1 | 1 | 2004 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Government | 1 | 0 | 1 | 2018 |
| Pennsylvania State University | Academic/Hospital | 1 | 0 | 1 | 2018 |
| Pharma Nord | For profit | 1 | 0 | 1 | 2004 |
| Second Military Medical University | Government | 1 | 0 | 1 | 2021 |
| Sidero Bioscience, LLC | For profit | 1 | 1 | 1 | 2018 |
| Zagazig University | Academic/Hospital | 1 | 0 | 1 | 2015 |
| Ziauddin University | Academic/Hospital | 1 | 1 | 1 | 2021 |
16 organizations
Page 1 / 1